Advertisement
Screener

Traws Pharma, Inc. (TRAW) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

Traws Pharma, Inc. Shares Authorized

Traws Pharma, Inc. (TRAW) had Shares Authorized of 250.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-14

  • 2026-06-30: Common Stock, Shares Authorized 250.00M shares.
  • 2026-03-31: Common Stock, Shares Authorized 250.00M shares.
  • 2025-12-31: Common Stock, Shares Authorized 250.00M shares.
  • 2025-09-30: Common Stock, Shares Authorized 250.00M shares.
Period endCommon Stock, Shares AuthorizedCommon Stock, Shares Authorized as first filed
2026-06-30250.00M shares
10-Q · filed 2026-08-14
2026-03-31250.00M shares
10-Q · filed 2026-05-15
2025-12-31250.00M shares
10-Q · filed 2026-08-14
2025-09-30250.00M shares
10-Q · filed 2025-11-13
2025-06-30250.00M shares
10-Q · filed 2025-08-14
2025-03-31250.00M shares
10-Q · filed 2025-05-15
2024-12-31250.00M shares
10-K · filed 2026-04-15
2024-09-30250.00M shares
10-Q · filed 2024-11-14
2024-06-30125.00M shares
10-Q · filed 2024-08-15
2024-04-01125.00M shares
10-K · filed 2025-03-31
2024-03-31125.00M shares
10-Q · filed 2024-05-15
2023-12-31250.00M shares
10-K · filed 2025-03-31
125.00M shares
10-K · filed 2024-04-01
2023-09-30125.00M shares
10-Q · filed 2023-11-14
2023-06-30125.00M shares
10-Q · filed 2023-08-14
2023-03-31125.00M shares
10-Q · filed 2023-05-15
2022-12-31125.00M shares
10-K · filed 2024-04-01
2022-09-30125.00M shares
10-Q · filed 2022-11-14
2022-06-30125.00M shares
10-Q · filed 2022-08-15
2022-03-31125.00M shares
10-Q · filed 2022-05-13
2021-12-31125.00M shares
10-K · filed 2023-03-30
2021-09-30125.00M shares
10-Q · filed 2021-11-15
2021-06-30125.00M shares
10-Q · filed 2021-08-16
2021-05-20125.00M shares
10-K · filed 2023-03-30
2021-05-19250.00M shares
10-K · filed 2023-03-30
2021-03-31250.00M shares
10-Q · filed 2021-05-17
2020-12-31250.00M shares
10-K · filed 2022-03-21
2020-09-30250.00M shares
10-Q · filed 2020-11-16
2020-06-30250.00M shares
10-Q · filed 2020-08-12
2020-03-31250.00M shares
10-Q · filed 2020-05-15
2019-12-31250.00M shares
10-K · filed 2021-03-18
2019-09-30250.00M shares
10-Q · filed 2019-11-12
2019-06-30250.00M shares
10-Q · filed 2019-08-14
2019-03-31250.00M shares
10-Q · filed 2019-05-15
2018-12-31250.00M shares
10-K · filed 2020-03-27
2018-09-30250.00M shares
10-Q · filed 2018-11-14
2018-06-30250.00M shares
10-Q · filed 2018-08-14
2018-06-07250.00M shares
10-K · filed 2020-03-27
2018-06-06100.00M shares
10-Q · filed 2019-08-14
2018-03-31100.00M shares
10-Q · filed 2018-05-15
2018-03-21100.00M shares
10-K · filed 2020-03-27
2018-03-2025.00M shares
10-Q · filed 2019-08-14
2017-12-3125.00M shares
10-K · filed 2020-03-27
2017-09-3025.00M shares
10-Q · filed 2017-11-09
2017-06-3025.00M shares
10-Q · filed 2017-08-14
2017-06-08250.00M shares
10-Q · filed 2019-05-15
2017-06-07100.00M shares
10-Q · filed 2019-05-15
2017-03-3125.00M shares
10-Q · filed 2017-05-15
2016-12-3125.00M shares
10-K · filed 2018-03-16
2016-09-3025.00M shares
10-Q · filed 2016-11-14
2016-06-3025.00M shares
10-Q · filed 2016-08-15
2016-05-3125.00M shares
10-K · filed 2018-03-16
2016-05-3075.00M shares
10-K · filed 2018-03-16
2016-03-3175.00M shares
10-Q · filed 2016-05-11
2015-12-3175.00M shares
10-K · filed 2017-03-29
2015-09-3075.00M shares
10-Q · filed 2015-11-12
2015-06-3075.00M shares
10-Q · filed 2015-08-13
2015-03-3175.00M shares
10-Q · filed 2015-05-15
2014-12-3175.00M shares
10-K · filed 2016-03-28
2014-09-3075.00M shares
10-Q · filed 2014-11-14
2014-06-3075.00M shares
10-Q · filed 2014-08-14
2014-03-3175.00M shares
10-Q · filed 2014-05-15
2013-12-3175.00M shares
10-K · filed 2015-03-30
2013-09-3075.00M shares
10-Q · filed 2013-11-14
2013-06-3030.15M shares
10-Q · filed 2013-09-06
2012-12-3130.15M shares
10-K · filed 2014-03-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Imunon, Inc. (IMNN)United States$0.008B-0.56
SOLIGENIX, INC. (SNGX)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
EXICURE, INC. (XCUR)United States$0.008B-1.54
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B